M. Hutchings and L. Specht, PET/CT in the management of haematological malignancies, European Journal of Haematology, vol.90, issue.1, pp.369-80, 2008.
DOI : 10.1097/00003072-200410000-00010

A. Gallamini and L. Kostakoglu, Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?, Blood, vol.120, issue.25, pp.4913-4933, 2012.
DOI : 10.1182/blood-2012-03-403790

C. Fermé and O. Reman, Lymphome de Hodgkin de l'adulte. EMC -Hématologie, pp.115-134, 2004.

L. Remontet, Cancer incidence and mortality in France over the period, Rev Epidemiol Sante Publique, vol.51, issue.1, pp.3-30, 1978.
URL : https://hal.archives-ouvertes.fr/hal-00428273

T. M. Mack, Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease, New England Journal of Medicine, vol.332, issue.7, pp.332-413, 1995.
DOI : 10.1056/NEJM199502163320701

G. Niedobitek, Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis, Blood, vol.90, issue.4, pp.1664-72, 1997.

J. Thariat, Cerebellar relapse of Hodgkin lymphoma, Leukemia & Lymphoma, vol.2, issue.4, pp.659-62, 2009.
DOI : 10.1111/j.1365-2141.2008.06998.x

F. Peyrade, [Rectal Hodgkin's disease in a patient with HIV infection], Presse Med, issue.37, pp.22-1883, 1993.

T. C. Kwee, R. M. Kwee, and R. A. Nievelstein, Imaging in staging of malignant lymphoma: a systematic review, Blood, vol.111, issue.2, pp.504-520, 2008.
DOI : 10.1182/blood-2007-07-101899

T. C. El-galaly, Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography???Staged Treatment-Naive Patients With Hodgkin Lymphoma, Journal of Clinical Oncology, vol.30, issue.36, pp.30-4508, 2012.
DOI : 10.1200/JCO.2012.42.4036

S. Muzahir, F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma, The British Journal of Radiology, vol.85, issue.1016, pp.85-490, 1016.
DOI : 10.1259/bjr/29583493

T. A. Lister, Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials, J Clin Oncol Blood, vol.7, issue.111, pp.1964-1987, 1989.

N. Martis and N. Mounier, Hodgkin Lymphoma in Patients with HIV Infection: A Review, Current Hematologic Malignancy Reports, vol.50, issue.4, pp.228-262, 2012.
DOI : 10.1007/s11899-012-0125-2

N. Mounier, M. Spina, and J. P. Spano, Hodgkin Lymphoma in HIV Positive Patients, Current HIV Research, vol.8, issue.2, pp.141-147, 2010.
DOI : 10.2174/157016210790442704

R. O. Casasnovas, Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte, Journal of Clinical Oncology, vol.25, issue.13, pp.25-1732, 2007.
DOI : 10.1200/JCO.2006.08.1331

D. Hasenclever and V. Diehl, A Prognostic Score for Advanced Hodgkin's Disease, New England Journal of Medicine, vol.339, issue.21
DOI : 10.1056/NEJM199811193392104

A. Gallamini, The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease, Haematologica, vol.91, issue.4, pp.475-81, 2006.

M. Sieber, A. Engert, and V. Diehl, Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group, Annals of Oncology, vol.11, issue.suppl 1, pp.81-86, 2000.
DOI : 10.1093/annonc/11.suppl_1.S81

A. Engert, Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study, Journal of Clinical Oncology, vol.27, issue.27, pp.27-4548, 2009.
DOI : 10.1200/JCO.2008.19.8820

P. Pommier, Impact of 18F-Fluoro-2-Deoxyglucose Positron Emission Tomography on Treatment Strategy and Radiotherapy Planning for Stage I???II Hodgkin Disease: A Prospective Multicenter Study, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.3, pp.79-823, 2011.
DOI : 10.1016/j.ijrobp.2009.11.048

J. O. Armitage, Early-Stage Hodgkin's Lymphoma, New England Journal of Medicine, vol.363, issue.7, pp.653-62, 2010.
DOI : 10.1056/NEJMra1003733

C. Ferme, Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease, New England Journal of Medicine, vol.357, issue.19
DOI : 10.1056/NEJMoa064601

N. Mounier and C. Ferme, [Particularities of Hodgkin's lymphoma], Rev Prat, vol.60, issue.1, pp.75-84, 2010.

B. D. Cheson, Revised Response Criteria for Malignant Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.579-86, 2007.
DOI : 10.1200/JCO.2006.09.2403

M. Soret, G. B. , E. Gontier, and H. Foehrenbach, Principe et technique de la tomographie d'??mission de positons coupl??e ?? la tomodensitom??trie, EMC -Radiologie et Imagerie Médicale : Principes et techniques -Radioprotection, pp.35-310, 2010.
DOI : 10.1016/S1879-8497(10)72881-8

S. Baba, Impact of FDG-PET/CT in the management of lymphoma, Annals of Nuclear Medicine, vol.23, issue.Suppl. 5, pp.701-717, 2011.
DOI : 10.1007/s12149-011-0549-0

T. Papajík, Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin???s lymphoma, European Journal of Haematology, vol.50, issue.1, pp.32-37, 2011.
DOI : 10.1111/j.1600-0609.2010.01532.x

J. Y. Ngeow, High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma, Annals of Oncology, vol.20, issue.9, pp.1543-1550, 2009.
DOI : 10.1093/annonc/mdp030

R. Munker, Contribution of PET imaging to the initial staging and prognosis of patients with Hodgkin's disease, Annals of Oncology, vol.15, issue.11, pp.15-1699, 2004.
DOI : 10.1093/annonc/mdh426

L. Rigacci, Positron emission tomography in the staging of patients with Hodgkin???s lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi, Annals of Hematology, vol.25, issue.Suppl 1, pp.86-897, 2007.
DOI : 10.1007/s00277-007-0356-9

B. D. Cheson, Role of Functional Imaging in the Management of Lymphoma, Journal of Clinical Oncology, vol.29, issue.14, pp.1844-54, 2011.
DOI : 10.1200/JCO.2010.32.5225

D. M. Kent and R. A. Hayward, Limitations of Applying Summary Results of Clinical Trials to Individual Patients, JAMA, vol.298, issue.10, pp.298-1209, 2007.
DOI : 10.1001/jama.298.10.1209

R. Guignard, PET scan integration in lymphoma management, International Journal of Hematologic Oncology, vol.2, issue.2, pp.121-135, 2013.
DOI : 10.2217/ijh.13.11

A. Engert, Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma, New England Journal of Medicine, vol.363, issue.7, pp.640-52, 2010.
DOI : 10.1056/NEJMoa1000067

M. Hutchings, FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma, Blood, vol.107, issue.1, pp.52-61, 2006.
DOI : 10.1182/blood-2005-06-2252

M. Hutchings, Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma, Annals of Oncology, vol.16, issue.7, pp.16-1160, 2005.
DOI : 10.1093/annonc/mdi200

D. J. Sher, Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy, Annals of Oncology, vol.20, issue.11, pp.20-1848, 2009.
DOI : 10.1093/annonc/mdp071

J. Radford, O. D. Barrington, S. Qian, W. Popova, and B. , Pettengl R Results of the 3rd planned interim analysis of the UK NCRI RAPID Trial (Involved field radiotherapy versus no further treatment) in patients with clinical stage IA/IIA Hodgkin Lymphoma and a " negative " 18FDG- PET scan after 3 cycles of ABVD, 2011.

A. Gallamini, F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study, Journal of Clinical Oncology, vol.25, issue.24, pp.25-3746, 2007.
DOI : 10.1200/JCO.2007.11.6525

A. Gallamini and M. O. Doherty, Report of satellite workshop on interim-PET in Hodgkin lymphoma, 8th International Symposium on Hodgkin Lymphoma, 2010.

A. Gallamini, T. C. Patti, C. Gianni, A. Bolis, S. Trentin et al., Multicentre Clinical Study with early treatment intensification in high-risk Hodgkin Lymphoma (HL) patients with a positive FDG- PET scan after two ABVD courses ? GITIL HD0607 study, 2011.

M. Meignan, Report on the First International Workshop on interim-PET scan in lymphoma, Leukemia & Lymphoma, vol.50, issue.8, pp.50-1257, 2009.
DOI : 10.1007/s00259-008-0787-0

T. Terasawa, 18F-FDG PET for Posttherapy Assessment of Hodgkin's Disease and Aggressive Non-Hodgkin's Lymphoma: A Systematic Review, Journal of Nuclear Medicine, vol.49, issue.1, pp.13-21, 2008.
DOI : 10.2967/jnumed.107.039867

M. E. Juweid, Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma, Journal of Clinical Oncology, vol.25, issue.5, pp.571-579, 2007.
DOI : 10.1200/JCO.2006.08.2305

J. J. Cerci, Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy, Journal of Clinical Oncology, vol.28, issue.8, pp.28-1415, 2010.
DOI : 10.1200/JCO.2009.25.4367

J. M. Zijlstra, 18F-fluoro-deoxyglucose positron emission tomography for posttreatment evaluation of malignant lymphoma: a systematic review, Haematologica, vol.91, issue.4, pp.522-531, 2006.

A. Engert, Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label

M. Magagnoli, M. K. Balzarotti, and M. , Dimension of Residual CT Scan Mass in Hodgkin's Lymphoma (HL) Is a Negative Prognostic Factor in Patients with PET Negative After Chemo+/- Radiotherapy, 2011.

J. A. Barnes, End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma, Annals of Oncology, vol.22, issue.4, pp.910-915, 2011.
DOI : 10.1093/annonc/mdq549

D. J. Sher, Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy, Annals of Oncology, vol.20, issue.11, pp.20-1848, 2009.
DOI : 10.1093/annonc/mdp071

C. Furth, F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial, Journal of Clinical Oncology, vol.27, issue.26, pp.27-4385, 2009.
DOI : 10.1200/JCO.2008.19.7814

E. Lopci, Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin???s disease, European Journal of Nuclear Medicine and Molecular Imaging, vol.37, issue.3, pp.1620-1627, 2011.
DOI : 10.1007/s00259-011-1836-7

B. D. Cheson, Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas, Journal of Clinical Oncology, vol.17, issue.4, p.1244, 1999.
DOI : 10.1200/JCO.1999.17.4.1244

S. F. Barrington, Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.10, pp.37-1824, 2010.
DOI : 10.1007/s00259-010-1490-5

M. Meignan, Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma and Menton 2011 consensus, Leuk Lymphoma, issue.10, pp.26-27, 2011.

A. Gallamini, Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation, Leukemia & Lymphoma, vol.17, issue.2, pp.50-1761, 2009.
DOI : 10.1200/JCO.2009.22.4089

M. Meignan, Report on the Second International Workshop on interim positron emission tomography in lymphoma, Leuk Lymphoma, issue.12, pp.51-2171, 2010.

A. Biggi, International Validation Study for Interim PET in ABVD-Treated

E. Itti, An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ??SUVmax, European Journal of Nuclear Medicine and Molecular Imaging, vol.119, issue.Suppl 1, 2013.
DOI : 10.1007/s00259-013-2435-6

B. E. Hillner, Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry, Journal of Nuclear Medicine, vol.49, issue.12, pp.49-1928, 2008.
DOI : 10.2967/jnumed.108.056713

O. Schillaci, Use of Dual-Point Fluorodeoxyglucose Imaging to Enhance Sensitivity and Specificity, Seminars in Nuclear Medicine, vol.42, issue.4, pp.267-80, 2012.
DOI : 10.1053/j.semnuclmed.2012.02.003

E. K. Pauwels, FDG Accumulation and Tumor Biology, Nuclear Medicine and Biology, vol.25, issue.4, pp.317-339, 1998.
DOI : 10.1016/S0969-8051(97)00226-6

H. Zhuang, Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes, J Nucl Med, vol.42, issue.9, pp.1412-1419, 2001.

C. Love, FDG PET of Infection and Inflammation, RadioGraphics, vol.25, issue.5, pp.1357-68, 2005.
DOI : 10.1148/rg.255045122

O. Schillaci, Hybrid imaging systems in the diagnosis of osteomyelitis and prosthetic joint infection, Q J Nucl Med Mol Imaging, vol.53, issue.1, pp.95-104, 2009.

S. Yamada, High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue, J Nucl Med, vol.36, issue.7, pp.1301-1307, 1995.

U. Metser and E. Even-sapir, Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT, Semin Nucl Med, issue.3, pp.37-206, 2007.

L. Bensimhon, Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study, Clin Microbiol Infect, issue.6, pp.17-836, 2011.

K. Kubota, Advantage of delayed whole-body FDG-PET imaging for tumour detection, European Journal of Nuclear Medicine, vol.28, issue.6
DOI : 10.1007/s002590100537

T. Higashi, Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer, J Nucl Med, vol.43, issue.2, pp.173-80, 2002.

A. J. Fischman and N. M. Alpert, FDG-PET in oncology: there's more to it than looking at pictures, J Nucl Med, vol.34, issue.1, pp.6-11, 1993.

L. M. Hamberg, The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?, J Nucl Med, issue.8, pp.35-1308, 1994.

M. A. Lodge, A PET study of 18 FDG uptake in soft tissue masses, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.1, pp.22-30, 1999.
DOI : 10.1007/s002590050355

A. R. Boerner, Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.3, pp.226-256, 1999.
DOI : 10.1007/s002590050381

R. Hustinx, Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck, European Journal of Nuclear Medicine, vol.26, issue.10, pp.26-1345, 1999.
DOI : 10.1007/s002590050593

A. Matthies, Dual time point 18F-FDG PET for the evaluation of pulmonary nodules, J Nucl Med, issue.7, pp.43-871, 2002.

K. Alkhawaldeh, Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.suppl, pp.246-52, 2008.
DOI : 10.1007/s00259-007-0584-1

O. Schillaci, Accuratezza della FDG PET-TC in fase precoce e in fase tardiva e della TC con mezzo di contrasto nella valutazione dei noduli polmonari: uno studio preliminare su 30 pazienti, La radiologia medica, vol.47, issue.6, pp.890-906, 2009.
DOI : 10.1007/s11547-009-0400-z

C. J. Chen, F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5, American Journal of Roentgenology, vol.191, issue.2, pp.475-484, 2008.
DOI : 10.2214/AJR.07.3457

R. L. Barger, K. R. Jr, and . Nandalur, Diagnostic Performance of Dual-time 18F-FDG PET in the Diagnosis of Pulmonary Nodules: A Meta-analysis, Academic Radiology, vol.19, issue.2, pp.153-161, 2012.
DOI : 10.1016/j.acra.2011.10.009

L. Zhang, single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis, Acta Radiologica, vol.21, issue.7, 2013.
DOI : 10.1177/0284185113481594

D. Uesaka, Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer, Journal of Nuclear Medicine, vol.49, issue.10, pp.49-1606, 2008.
DOI : 10.2967/jnumed.108.051250

T. Shinya, Dual-Time-Point F-18 FDG PET/CT for Evaluation of Intrathoracic Lymph Nodes in Patients With Non-Small Cell Lung Cancer, Clinical Nuclear Medicine, vol.34, issue.4, pp.216-237, 2009.
DOI : 10.1097/RLU.0b013e31819a1f3d

S. J. Kim, Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC Patients, Clinical Nuclear Medicine, vol.36, issue.6, pp.36-434, 2011.
DOI : 10.1097/RLU.0b013e31820adef8

M. Houseni, Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung, Journal of Nuclear Medicine, vol.51, issue.4, pp.535-577, 2010.
DOI : 10.2967/jnumed.109.068643

R. Kumar, Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET, J Nucl Med, issue.11, pp.46-1819, 2005.

A. Mavi, Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes, J Nucl Med, issue.9, pp.47-1440, 2006.

W. H. Choi, The value of dual-time-point 18F-FDG PET/CT for identifying axillary lymph node metastasis in breast cancer patients, Br J Radiol, pp.84-593, 1003.

D. L. Costantini, Dual???Time-Point FDG PET/CT for the Evaluation of Pediatric Tumors, American Journal of Roentgenology, vol.200, issue.2, pp.408-421, 2013.
DOI : 10.2214/AJR.12.8930

S. J. Kim, Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules, Annals of Nuclear Medicine, vol.29, issue.5, pp.347-53, 2011.
DOI : 10.1007/s12149-011-0468-0

R. Abgral, Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma, Nuclear Medicine Communications, vol.34, issue.6, pp.34-551, 2013.
DOI : 10.1097/MNM.0b013e32836089ab

URL : https://hal.archives-ouvertes.fr/hal-00831504

E. Akkas and B. , FDG uptake in brown adipose tissue???A brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT, Revista Espa??ola de Medicina Nuclear, vol.30, issue.1, pp.14-22, 2011.
DOI : 10.1016/j.remn.2010.05.006

A. Toriihara, Normal variants of bowel FDG uptake in dual-time-point PET/CT imaging, Annals of Nuclear Medicine, vol.35, issue.3
DOI : 10.1007/s12149-010-0439-x

M. M. Sathekge, Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis, S Afr Med J Respirology, vol.100, issue.164, pp.713-733, 2010.

T. Shinya, Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma, Annals of Nuclear Medicine, vol.23, issue.8, pp.26-616, 2012.
DOI : 10.1007/s12149-012-0619-y

M. Nakayama, Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions, Annals of Nuclear Medicine, vol.26, issue.2, pp.163-172, 2013.
DOI : 10.1007/s12149-012-0669-1

R. S. Gawande, Differentiation of Normal Thymus from Anterior Mediastinal Lymphoma and Lymphoma Recurrence at Pediatric PET/CT, Radiology, vol.262, issue.2, pp.613-635, 2012.
DOI : 10.1148/radiol.11110715

H. Necib, Detection and Characterization of Tumor Changes in 18F-FDG PET Patient Monitoring Using Parametric Imaging, Journal of Nuclear Medicine, vol.52, issue.3, pp.354-61, 2011.
DOI : 10.2967/jnumed.110.080150

J. W. Keyes and . Jr, SUV: standard uptake or silly useless value?, J Nucl Med, vol.36, issue.10, pp.1836-1845, 1995.

M. Soret, S. L. Bacharach, and I. Buvat, Partial-Volume Effect in PET Tumor Imaging, Journal of Nuclear Medicine, vol.48, issue.6, pp.932-977, 2007.
DOI : 10.2967/jnumed.106.035774

S. A. Nehmeh and Y. E. Erdi, Respiratory Motion in Positron Emission Tomography/Computed Tomography: A Review, Seminars in Nuclear Medicine, vol.38, issue.3, pp.167-76, 2008.
DOI : 10.1053/j.semnuclmed.2008.01.002

M. Reyes, Model-based respiratory motion compensation for emission tomography image reconstruction, Physics in Medicine and Biology, vol.52, issue.12, pp.3579-600, 2007.
DOI : 10.1088/0031-9155/52/12/016

URL : https://hal.archives-ouvertes.fr/inria-00616030